Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Oertli Commercial Launch of OS 4 Up
News Research & Innovations

Commercial Launch of OS 4 Up

Platform features newly developed Phaco Assisted Cataract Surgery (PACS) modulation

3/6/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
Objective:

To introduce the OS 4 Up surgical platform for cataract and vitreoretinal surgery, emphasizing user-centric design and advanced technology.

Approach:
    Key Findings:
    • Phaco Assisted Cataract Surgery (PACS) enhances classic phacoemulsification with real-time energy adjustment.
    • Dynamic infusion compensates for intraocular pressure fluctuations, allowing for physiological IOP settings.
    • The platform aims to improve the surgical experience by making it intuitive, safe, and enjoyable.
    Interpretation:

    The OS 4 Up represents a significant advancement in surgical technology, focusing on precision and user experience to enhance surgical outcomes.

    Limitations:
    • No specific clinical trial data or performance metrics provided in the announcement.
    • Potential need for training on new features for existing surgical teams.
    Conclusion:

    The OS 4 Up is positioned as a transformative tool in cataract and vitreoretinal surgery, prioritizing surgeon comfort and operational efficiency.

    Sources:
    • Oertli Instrumente AG Press Release

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: